1,779
Views
29
CrossRef citations to date
0
Altmetric
Research Paper

Vaccination perspectives among adolescents and their desired role in the decision-making process

, , , , & ORCID Icon
Pages 1752-1759 | Received 06 Sep 2018, Accepted 10 Jan 2019, Published online: 14 Mar 2019

References

  • National Foundation for Infectious Diseases. Call to action: addressing new and ongoing adolescent vaccination challenges; 2016 [accessed 2018 Jan 23]. http://www.nfid.org/homepage/additional-offerings/call-to-action-adolescent-vaccination-challenges.pdf.
  • CDC. Notice to readers: recommended childhood immunization schedule – United States; 2000 [accessed 2018 Mar 1]. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm4902a4.htm.
  • Recommended immunization schedule for children and adolescents aged 18 years or younger, United States; 2018 [accessed 2018 Mar 1]. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf.
  • Healthy people 2020 national immunization goals; 2015 [accessed 2018 Mar 1]. https://www.doh.wa.gov/Portals/1/Documents/Pubs/348-458-HealthyPeople2020Immunization Goals.pdf.
  • Reiter PL, Stubbs B, Panozzo CA, Whitesell D, Brewer NT. HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2354–61. doi:10.1158/1055-9965.
  • Tan TQ, Gerbie MV. Perception, awareness, and acceptance of human papillomavirus disease and vaccine among parents of boys aged 9 to 18 years. Clin Pediatr. 2016;56(8):737–43. doi:10.1177/0009922816682788.
  • Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764. doi:10.1542/peds.2016-1764.
  • VanWormer JJ, Bendixsen CG, Vickers ER, Stokley S, McNeil MM, Gee J, Belongia EA, McLean HQ. Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents. BMC Public Health. 2017;17(1):766. doi:10.1186/s12889-017-4787-5.
  • Shapiro GK, Tatar O, Amsel R, Prue G, Zimet GD, Knauper B, Rosberger Z. Using an integrated conceptual framework to investigate parents’ HPV vaccine decision for their daughters and sons. Prev Med. 2018;116:203–10. doi:10.1016/j.ypmed.2018.09.017.
  • Dube E, Gagnon D, MacDonald N, Bocquier A, Peretti-Watel P, Verger P. Underlying factors impacting vaccine hesitancy in high income countries: A review of qualitative studies. Expert Rev Vaccines. 2018;17(11):989–1004. doi:10.1080/14760584.2018.1541406.
  • Gowda C, Schaffer SE, Dombkowski KJ, Dempsey AF. Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers. BMC Public Health. 2012;12:509. doi:10.1186/1471-2458-12-509.
  • McRee AL, Reiter PL, Brewer NT. Vaccinating adolescent girls against human papillomavirus-who decides? Prev Med. 2010;50(4):213–14. doi:10.1016/j.ypmed.2010.02.001.
  • Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr. 2011;11(1):74. doi:10.1186/1471-2431-11-74.
  • Chang J, Ipp LS, de Roche AM, Catallozzi M, Breitkopf CR, Rosenthal SL. Adolescent-parent dyad descriptions of the decision to start the HPV vaccine series. J Pediatr Adolesc Gynecol. 2018;31(1):28–32. doi:10.1016/j.jpag.2017.10.003.
  • Huh WK, Joura EA, Giuliano AR, Iversen O-E, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet. 2017;390(10108):2143–59. doi:10.1016/S0140-6736(17)31821-4.
  • Kavanagh K, Pollock KG, Cuschieri K, Palmer T, Cameron RL, Watt C, Bhatia R, Moore C, Cubie H, Cruickshank M, et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis. 2017;17(12):1293–302. doi:10.1016/S1473-3099(17)30468-1.
  • Luostarinen T, Apter D, Dillner J, Eriksson T, Harjula K, Natunen K, Paavonen J, Pukkala E, Lehtinen M. Vaccination protects against invasive HPV-associated cancers. Int J Cancer. 2018;142(10):2186–87. doi:10.1002/ijc.31231.
  • Kjaer SK, Nygard M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, et al. A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 nordic countries. Clin Infect Dis. 2018;66(3):339–45. doi:10.1093/cid/cix797.
  • Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(33):909–17. doi:10.15585/mmwr.mm6733a1.
  • Siddiqui M, Salmon DA, Omer SB. Epidemiology of vaccine hesitancy in the United States. Hum Vaccin Immunother. 2013;9(12):2643–48. doi:10.4161/hv.27243.
  • Allison MA, Hurley LP, Markowitz L, Crane LA, Brtnikova M, Beaty BL, Snow M, Cory J, Stokley S, Roark J, et al. Primary care physicians’ perspectives about HPV vaccine. Pediatrics. 2016;137(2):e20152488. doi:10.1542/peds.2015-2488.
  • Patel PR, Berenson AB. Sources of HPV vaccine hesitancy in parents. Hum Vaccin Immunother. 2013;9(12):2649–53. doi:10.4161/hv.26224.
  • Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014–United States. MMWR Morb Mortal Wkly Rep. 2014;63:620–24.
  • Brelsford D, Knutzen E, Neher JO, Safranek S. Clinical Inquiries: which interventions are effective in managing parental vaccine refusal? J Fam Pract. 2017;66:E12–e14.
  • Mullins TL, Griffioen AM, Glynn S, Zimet GD, Rosenthal SL, Fortenberry JD, Kahn JA. Human papillomavirus vaccine communication: perspectives of 11-12 year-old girls, mothers, and clinicians. Vaccine. 2013;31(42):4894–901. doi:10.1016/j.vaccine.2013.07.033.
  • Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19(8):531–38. doi:10.1016/j.annepidem.2009.03.011.
  • Sopracordevole F, Cigolot F, Mancioli F, Agarossi A, Boselli F, Ciavattini A. Knowledge of HPV infection and vaccination among vaccinated and unvaccinated teen-aged girls. Int J Gynecol Obstet. 2013;122(1):48–51. doi:10.1016/j.ijgo.2013.02.011.
  • Sturm L, Donahue K, Kasting M, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings. J Adolesc Health. 2017 Aug;61(2):246–51. Epub 2017 Apr 25. doi:10.1016/j.jadohealth.2017.02.006.
  • Shay LA, Baldwin AS, Betts AC, Marks EG, Higashi RT, Street RL Jr, Persaud D, Tiro JA. Parent-provider communication of HPV vaccine hesitancy. Pediatrics. 2018 Jun;141(6):pii: e20172312. Epub 2018 May 15. doi:10.1542/peds.2017-2312.
  • Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med. 2015 Aug;77:181–85. Epub 2015 Jun 4. doi:10.1016/j.ypmed.2015.05.024.
  • Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14:700. doi:10.1186/1471-2458-14-700.
  • Lacombe-Duncan A, Newman PA, Baiden P. Human papillomavirus vaccine acceptability and decision-making among adolescent boys and parents: A meta-ethnography of qualitative studies. Vaccine. 2018;36(19):2545–58. doi:10.1016/j.vaccine.2018.02.079.
  • Mohammed KA, Geneus CJ, Osazuwa-Peters N, Adjei Boakye E, Tobo BB, Burroughs TE. Disparities in provider recommendation of human papillomavirus vaccination for U.S. Adolescents. J Adolesc Health. 2016;59(5):592–98. doi:10.1016/j.jadohealth.2016.06.005.
  • Recommendations on the use of quadrivalent human papillomavirus vaccine in males—advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–08. doi:10.1186/1471-2431-11-74.
  • Bednarczyk RA, Chu SL, Sickler H, Shaw J, Nadeau JA, McNutt LA. Low uptake of influenza vaccine among university students: evaluating predictors beyond cost and safety concerns. Vaccine. 2015;33(14):1659–63. doi:10.1016/j.vaccine.2015.02.033.
  • Federal Centre for Health Education, BZgA. WHO regional office for Europe and BZgA standards for sexual education in Europe: a framework for policy makers, educational and health authorities, and specialists. Colonge. 2010 [accessed 2018 Nov 9]. https://www.oif.ac.at/fileadmin/OEIF/andere_Publikationen/WHO_BZgA_Standards.pdf.
  • Laidsaar-Powell KJM, Mather T, Juraskova I. Vaccination decision-making and HPV knowledge: how informed and engaged are young adult HPV vaccine recipients in Australia? 2014:ID 495347, 9. doi:10.1155/2014/495347.
  • Guzman GG Household income, 2016: American community survey brief. US Census Bureau; 2017 [ accessed 2018 Nov 6]. https://www.census.gov/content/dam/Census/library/publications/2017/acs/acsbr16-02.pdf.
  • United States Census Bureau. American community survey, 2016 American community survey 5-year estimates, table [blinded]; generated by LA McNutt; using American FactFinder; [accessed 2018 Nov 5]. http://factfinder2.census.gov.
  • CDC. 2013 handbook for conducting youth risk behavior surveys. Atlanta (GA): US Department of Health and Human Services, CDC; 2012 [accessed 2018 Nov 9]. https://www.cdc.gov/healthyyouth/data/yrbs/overview.htm.
  • Brener ND, Kann L, Shanklin S, Shanklin S, Kinchen S, Eaton DK, Hawkins J, Flint KH. Methodology of the youth risk behavior surveillance system–2013. MMWR Recomm Rep. 2013;62:1–20.
  • Bethell C, Klein J, Peck C. Assessing health system provision of adolescent preventive services: the young adult health care survey. Med Care. 2001;39:478–90.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.